StockWatch
·
Biotechnology: Pharmaceutical Preparations
Corporate ActionJun 9, 2026, 04:19 PM

Shattuck Labs Commences Public Offering of Common Stock

AI Summary

Shattuck Labs, Inc. announced the commencement of a public offering of its common stock, or pre-funded warrants to purchase common stock, for certain investors. The company also expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the common stock. The offering is subject to market and other conditions, with Leerink Partners, J.P. Morgan, Piper Sandler, and Cantor acting as joint bookrunning managers.

Key Highlights

  • Shattuck Labs commenced a public offering of common stock or pre-funded warrants.
  • Underwriters have a 30-day option to purchase up to an additional 15% of common stock.
  • Leerink Partners, J.P. Morgan, Piper Sandler, and Cantor are joint bookrunning managers.
  • All securities are being offered by Shattuck Labs.
  • A registration statement for these securities was declared effective on January 21, 2026.